Are prostatitis symptoms associated with an isoprostane-mediated vicious circle?

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 837-840

  Türk, Silver ^a   Kullisaar, Tiiu ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; ISOPROSTANE; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE;

ARTICLE; ELECTROPHILICITY; GENETIC POLYMORPHISM; HUMAN; LIPID PEROXIDATION; LOWER URINARY TRACT SYMPTOM; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PAIN; PATHOGENESIS; PROSTATITIS; SYMPTOM;

HUMANS; ISOPROSTANES; MALE; PROSTATITIS;

EID: 80053963966     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.050     Document Type: Article

References (52)

1. Nickel J.C. The prostatitis manual 2002, Bladon Medical Publishing, Chipping Norton, Oxfordshire, UK.
2. Alexander R.B., Propert K.J., Schaeffer A.J., et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141(8):581-589.
3. Nickel J.C., Downey J., Clark J., et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003, 62(4):614-617.
4. Goldmeier D., Madden P., McKenna M., Tamm N. Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study. Int J STD AIDS 2005, 16(3):196-200.
5. Nickel J.C., Pontari M., Moon T., et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003, 169(4):1401-1405.
6. Zhao W.P., Zhang Z.G., Li X.D., et al. Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). Braz J Med Biol Res 2009, 42(10):963-967.
7. Elist J. Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology 2006, 67(1):60-63.
8. Shoskes D.A., Zeitlin S.I., Shahed A., Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999, 54(6):960-963.
9. Wagenlehner F.M., Schneider H., Ludwig M., Schnitker J., Brähler E., Weidner W. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 2009, 56(3):544-551.
10. Kullisaar T., Türk S., Punab M., et al. Oxidative stress in leucocytospermic prostatitis patients: preliminary results. Andrologia 2008, 40(3):161-172.
11. Lou J.G., Dong J., Zheng Y.C., Zhang S.M., Xiao W.Q., Zhou J.F. Increased oxidative stress and damage in patients with chronic bacterial prostatitis. Biomed Environ Sci 2006, 19(6):481-486.
12. Morrow J.D. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des 2006, 12(8):895-902.
13. Musiek E.S., Breeding R.S., Milne G.L., Zanoni G., Morrow J.D., McLaughlin B. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J Neurochem 2006, 97(5):1301-1313.
14. Du S., Araki I., Kobayashi H., Zakoji H., Sawada N., Takeda M. Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology 2008, 72(2):450-455.
15. Gratzke C., Weinhold P., Reich O., et al. Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells. Eur Urol 2010, 57(5):902-910.
16. Stein R.J., Santos S., Nagatomi J., et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 2004, 172(3):1175-1178.
17. Taylor-Clark T.E., McAlexander M.A., Nassenstein C., et al. Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal. J Physiol 2008, 586(14):3447-3459.
18. Taylor-Clark T.E., Undem B.J., Macglashan D.W., Ghatta S., Carr M.J., McAlexander M.A. Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol Pharmacol 2008, 73(2):274-281.
19. Schwartz E.S., Kim H.Y., Wang J., et al. Persistent pain is dependent on spinal mitochondrial antioxidant levels. J Neurosci 2009, 29(1):159-168.
20. Schwartz E.S., Lee I., Chung K., Chung J.M. Oxidative stress in the spinal cord is an important contributor in capsaicin-induced mechanical secondary hyperalgesia in mice. Pain 2008, 138(3):514-524.
21. Pan Z., Yang H., Reinach P.S. Transient receptor potential (TRP) gene superfamily encoding cation channels. Hum Genomics 2011, 5(2):108-116.
22. Wollmuth L.P., Sakmann B. Different mechanisms of Ca2+ transport in NMDA and Ca2+-permeable AMPA glutamate receptor channels. J Gen Physiol 1998, 112(5):623-636.
23. Nicholls D.G. Oxidative stress and energy crises in neuronal dysfunction. Ann NY Acad Sci 2008, 1147:53-60.
24. Aikens J., Dix T.A. Perhydroxyl radical (HOO.) initiated lipid peroxidation. The role of fatty acid hydroperoxides. J Biol Chem 1991, 266(23):15091-15098.
25. Arisan E.D., Arisan S., Kiremit M.C., et al. Manganese superoxide dismutase polymorphism in chronic pelvic pain syndrome patients. Prostate Cancer Prostatic Dis 2006, 9(4):426-431.
26. McGrath C.E., Tallman K.A., Porter N.A., Marnett L.J. Structure-activity analysis of diffusible lipid electrophiles associated with phospholipid peroxidation: 4-hydroxynonenal and 4-oxononenal analogues. Chem Res Toxicol 2011, 24(3):357-370.
27. Rossato M.F., Velloso N.A., de Oliveira Ferreira A.P., de Mello C.F., Ferreira J. Spinal levels of nonprotein thiols are related to nociception in mice. J Pain 2010, 11(6):545-554.
28. Anand U., Otto W.R., Facer P., et al. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Neurosci Lett 2008, 438(2):221-227.
29. Kosugi M., Nakatsuka T., Fujita T., Kuroda Y., Kumamoto E. Activation of TRPA1 channel facilitates excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord. J Neurosci 2007, 27(16):4443-4451.
30. Uta D., Furue H., Pickering A.E., et al. TRPA1-expressing primary afferents synapse with a morphologically identified subclass of substantia gelatinosa neurons in the adult rat spinal cord. Eur J Neurosci 2010, 31(11):1960-1973.
31. Wei H., Chapman H., Saarnilehto M., Kuokkanen K., Koivisto A., Pertovaara A. Roles of cutaneous versus spinal TRPA1 channels in mechanical hypersensitivity in the diabetic or mustard oil-treated non-diabetic rat. Neuropharmacology 2010, 58(3):578-584.
32. Diogenes A., Akopian A.N., Hargreaves K.M. NGF up-regulates TRPA1: implications for orofacial pain. J Dent Res 2007, 86(6):550-555.
33. Miller L.J., Fischer K.A., Goralnick S.J., et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002, 59(4):603-608.
34. Yin H., Gao L., Tai H.H., Murphey L.J., Porter N.A., Morrow J.D. Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans. J Biol Chem 2007, 282(1):329-336.
35. Evans A.R., Junger H., Southall M.D., et al. Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons. J Pharmacol Exp Ther 2000, 293(3):912-920.
36. Muratani T., Nishizawa M., Matsumura S., et al. Functional characterization of prostaglandin F2alpha receptor in the spinal cord for tactile pain (allodynia). J Neurochem 2003, 86(2):374-382.
37. Lerea L.S., Carlson N.G., Simonato M., et al. Prostaglandin F2alpha is required for NMDA receptor-mediated induction of c-fos mRNA in dentate gyrus neurons. J Neurosci 1997, 17(1):117-124.
38. Berger R.E., Ciol M.A., Rothman I., Turner J.A. Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS. BMC Urol 2007, 7:17.
39. Hedelin H., Jonsson K. Chronic prostatitis/chronic pelvic pain syndrome: symptoms are aggravated by cold and become less distressing with age and time. Scand J Urol Nephrol 2007, 41(6):516-520.
40. Turini D., Beneforti P., Spinelli M., Malagutti S., Lazzeri M. Heat/burning sensation induced by topical application of capsaicin on perineal cutaneous area: new approach in diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome?. Urology 2006, 67(5):910-913.
41. Conrad M., Sato H. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 2011.
42. Tarcan T., Siroky M.B., Krane R.J., Azadzoi K.M. Isoprostane 8-epi PGF2alpha, a product of oxidative stress, is synthesized in the bladder and causes detrusor smooth muscle contraction. Neurourol Urodyn 2000, 19(1):43-51.
43. Kirby R.S., Lowe D., Bultitude M.I., Shuttleworth K.E. Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol 1982, 54(6):729-731.
44. Vega R.E. Distal urethral web: a risk factor in prostatitis. Prostate Cancer Prostatic Dis 2002, 5(3):180-182.
45. Alp B.F., Akyol I., Adayener C., et al. The significance of potassium chloride sensitivity test and urinary uronic acid level in the diagnosis of chronic pelvic pain syndrome. Int Urol Nephrol 2009, 41(3):483-489.
46. Parsons C.L. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 2007, 69(4 Suppl.):9-16.
47. Mändar R., Raukas E., Türk S., Korrovits P., Punab M. Mycoplasmas in semen of chronic prostatitis patients. Scand J Urol Nephrol 2005, 39(6):479-482.
48. Mazzoli S., Cai T., Rupealta V., Gavazzi A., Castricchi Pagliai R., Mondaini N., et al. Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur Urol 2007, 51(5):1385-1393.
49. Shoskes D.A., Lee C.T., Murphy D., Kefer J., Wood H.M. Incidence and significance of prostatic stones in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2007, 70(2):235-238.
50. Busolo F., Conventi L. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis. Eur J Clin Microbiol Infect Dis 1988, 7(3):407-410.
51. Zhou Z., Hong L., Shen X., Rao X., Jin X., Lu G., et al. Detection of nanobacteria infection in type III prostatitis. Urology 2008, 71(6):1091-1095.
52. Kładna A., Kruk I., Michalska T., Berczyński P., Aboul-Enein H.Y. Characterization of the superoxide anion radical scavenging activity by tetracycline antibiotics in aprotic media. Luminescence 2011.